METHOD FOR TREATING HUMAN DISEASES ASSOCIATED WITH AN INCREASED DEOXYRIBONUCLEIC ACID CONTENT IN EXTRACELLULAR SPACES OF TISSUES AND A MEDICINAL PREPARATION FOR CARRYING OUT SAID METHOD

(19)

(11)

EP 2 095 825 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	28.03.2012 Bulletin 2012/13

(45)	Mention of the grant of the patent:
	22.06.2011 Bulletin 2011/25

(21)	Application number: 06843990.0

(22)	Date of filing: 28.11.2006

(51)

International Patent Classification (IPC):

A61K 38/47^(2006.01)
A61K 9/20^(2006.01)
A61K 9/68^(2006.01)

A61K 9/02^(2006.01)
A61K 9/48^(2006.01)
A61P 43/00^(2006.01)

(86)	International application number:
	PCT/RU2006/000642

(87)	International publication number:
	WO 2008/066403 (05.06.2008 Gazette 2008/23)

(54)

METHOD FOR TREATING HUMAN DISEASES ASSOCIATED WITH AN INCREASED DEOXYRIBONUCLEIC ACID CONTENT IN EXTRACELLULAR SPACES OF TISSUES AND A MEDICINAL PREPARATION FOR CARRYING OUT SAID METHOD

VERFAHREN ZUR BEHANDLUNG VON KRANKHEITEN DES MENSCHEN IM ZUSAMMENHANG MIT EINEM ERHÖHTEN DESOXYRIBONUCLEINSÄUREGEHALT IN EXTRAZELLULÄREN RÄUMEN VON GEWEBEN UND MEDIZINISCHE ZUBEREITUNG ZUR DURCHFÜHRUNG DES VERFAHRENS

PROCÉDÉ DE TRAITEMENT DE MALADIES HUMAINES ACCOMPAGNÉES D'UNE TENEUR PLUS ÉLEVÉE D'ADN DANS DES ESPACES INTERCELLULAIRES ET PRÉPARATION MÉDICAMENTEUSE DESTINÉE À SA MISE EN OEUVRE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(43)	Date of publication of application:
	02.09.2009 Bulletin 2009/36

(73)	Proprietor: CLS Therapeutics Limited
	Guernsey GY1 3DR (GB)

(72)	Inventors:
	GENKIN, Dmitry Dmitrievich 197110, Saint-Petersburg (RU) TETS, Viktor Veniaminovich 196066, Saint -Petersburg (RU) TETS, Georgy Viktorovich 191040, Saint -Petersburg (RU)

(74)	Representative: Gulde Hengelhaupt Ziebig & Schneider
	Patentanwälte - Rechtsanwälte Wallstrasse 58/59 10179 Berlin 10179 Berlin (DE)

(56)

References cited: :

EP-A1- 1 655 036
WO-A1-97/47751
GB-A- 1 005 985
US-A- 5 484 589
US-A1- 2004 157 239

WO-A1-95/00170
WO-A2-2005/115444
RU-C1- 2 207 876
US-A1- 2003 044 403

DATABASE PUBMED [Online] VONMOOS P.L. ET AL.: 'Absorption and hematologic effect of streptokinase-streptodornase (varidase) after intracavital or oral administration', XP008110204 Database accession no. (394315) & SCHWEIZ MED WOCHENSCHR vol. 109, no. 41, 27 October 1979, pages 1538 - 1544

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).